AVEROA is an emerging company with a smart business focused on the development and registration of innovative drugs with high interest for patients with strong unmet medical needs.

Their goal is to build a strong pipeline focused on developing and registering products of high interest for patients with kidney or metabolic diseases. Their expertise lies in identifying innovative products with the potential to address significant medical needs in nephrology and advancing them to a stage of development that maximizes their therapeutic and commercial value.

–  Therapeutic areas: Nephrology and Metabolism, Endocrinology

–  Based in: Grenoble (FRANCE)

–  Employees: 1 – 10

– Created in: 2021